RTW Biotech Opportunities Ltd (LSE:RTW) a fund managed by RTW Investments, LP agreed to acquire Arix Biosciences Plc's assets from Arix Bioscience plc for Approximately £190 million on November 1, 2023.Herbert Smith Freehills LLP acted as legal advisor to RTW Biotech Opportunities Ltd managed by RTW Investments, LP
Arix Bioscience plc
Equities
ARIX
GB00BD045071
Investment Management & Fund Operators
1st Jan change | Capi. | |
---|---|---|
+31.41% | 12.02B | |
+14.40% | 3.06B | |
+2.96% | 1.42B | |
+1.15% | 616M | |
+35.79% | 577M | |
-10.84% | 579M | |
-4.17% | 492M | |
+33.85% | 488M | |
+3.90% | 304M |